North America Cardiac Arrhythmia Monitoring Devices Market: Market Size & Forecast 2026

North America represents the leading regional market for cardiac arrhythmia monitoring devices worldwide, supported by advanced healthcare infrastructure, high cardiovascular disease burden, and strong reimbursement coverage. The regional market is valued at approximately USD 8.53 billion in 2025 and is projected to expand at a CAGR of about 8.02% through the forecast period. Demand spans hospitals, ambulatory care, and home-based settings, reflecting the shift toward continuous and remote cardiac monitoring.

• •Regional market size estimated at USD 8.53 billion in 2025 with an 8.02% CAGR.
• •North America holds the largest global share, ranging from roughly 37% to 46.6% across industry estimates.
• •The U.S. accounts for the majority of regional revenue, with the U.S. sub-market valued near USD 3.0 billion in 2025.

The primary engine behind market expansion is the rising incidence of atrial fibrillation and other cardiac arrhythmias, particularly among adults over 65. Technological advances in miniaturization, Bluetooth-enabled wearables, and AI-driven arrhythmia detection are broadening clinical use cases beyond traditional Holter monitoring. Favorable Medicare and private-payer reimbursement for long-term monitoring, along with growing physician adoption of remote patient monitoring, is accelerating uptake.

• •Aging population and rising prevalence of atrial fibrillation are expanding the addressable patient pool.
• •AI-enabled ECG analysis and connected wearable patches are improving diagnostic yield and clinician workflow.
• •Reimbursement codes such as CPT 93241-93248 for mobile cardiac telemetry support broader clinical adoption.

The market is typically segmented by device type (ECG monitors, event recorders, Holter monitors, implantable loop recorders, and mobile cardiac telemetry), by end user (hospitals, ambulatory surgical centers, diagnostic centers, and home care), and by geography. Within North America, the United States dominates due to its larger patient base, higher per-capita healthcare spending, and earlier technology adoption, while Canada is growing steadily on the back of digital health initiatives. The ambulatory and home-care segments are expanding fastest as care moves outside hospital walls.

• •Mobile cardiac telemetry and wearable patch monitors are the fastest-growing device categories.
• •Hospitals remain the largest end-user segment, but home-care settings are gaining share.
• •The U.S. represents the bulk of regional revenue, with Canada contributing incremental growth.

What are the recent trends and outlook?

Looking ahead, the market is expected to benefit from the convergence of wearable hardware, cloud-based analytics, and AI-assisted diagnosis, enabling earlier detection of arrhythmias and reducing stroke-related complications. Regulatory clearances for next-generation devices and growing integration with electronic health records will further accelerate adoption. The regional market is on track to remain the global leader through 2030 and beyond, with sustained double-digit-billion-dollar revenue potential.

• •AI and machine-learning algorithms are becoming a standard feature in new arrhythmia monitors.
• •Integration with telehealth and remote patient monitoring platforms is reshaping care delivery.
• •Long-term, the market is expected to maintain its position as the largest and most technologically advanced regional segment worldwide.